Overview
A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
Indication
For management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.
Associated Conditions
- Diabetic Gastroparesis
- Dyspepsia
- Erosive Esophagitis
- Gastrointestinal Symptoms
- Non-erosive Reflux Esophagitis Disease (NERD)
- Upper gastrointestinal motility disorders
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2011/06/23 | Phase 3 | Withdrawn | Allegiance Health | ||
2011/05/18 | Phase 3 | Completed | |||
2011/05/04 | Not Applicable | Completed | |||
2010/12/10 | Phase 3 | Completed | IRCCS Burlo Garofolo | ||
2009/11/30 | Phase 1 | UNKNOWN | International College of Osteopathic Medicine | ||
2009/06/22 | N/A | Completed | |||
2009/04/02 | Not Applicable | Terminated | |||
2008/10/22 | Not Applicable | UNKNOWN | Arnold, George, M.D. | ||
2008/09/29 | Not Applicable | Terminated | |||
2008/09/26 | Phase 2 | Terminated |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Domperidone Capsules | 国药准字H20080608 | 化学药品 | 胶囊剂 | 3/17/2023 | |
| Domperidone Suspension | 国药准字H20094232 | 化学药品 | 口服混悬剂 | 8/22/2024 |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.